WA
DGX icon

Wasatch Advisors’s Quest Diagnostics DGX Stock Holding History

Wasatch Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.56M Sell
16,775
-927
-5% -$182K 0.02% 193
2026
Q1 		$3.47M Hold
17,702
– – 0.02% 181
2025
Q4 		$3.07M Sell
17,702
-54
-0.3% -$9.83K 0.02% 198
2025
Q3 		$3.38M Sell
17,756
-2,891
-14% -$513K 0.02% 203
2025
Q2 		$3.71M Sell
20,647
-1,000
-5% -$174K 0.02% 203
2025
Q1 		$3.66M Sell
21,647
-9,000
-29% -$1.48M 0.02% 203
2024
Q4 		$4.62M Sell
30,647
-2,000
-6% -$311K 0.02% 188
2024
Q3 		$5.07M Sell
32,647
-3,013
-8% -$450K 0.02% 195
2024
Q2 		$4.88M Hold
35,660
– – 0.03% 191
2024
Q1 		$4.75M Buy
+35,660
New +$4.63M 0.02% 201
2017
Q1 		– Sell
-14,276
Closed -$1.31M – 353
2016
Q4 		$1.31M Sell
14,276
-40,586
-74% -$3.5M 0.02% 294
2016
Q3 		$4.64M Sell
54,862
-52,821
-49% -$4.44M 0.07% 195
2016
Q2 		$8.77M Buy
+107,683
New +$8.2M 0.13% 152

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return

Wasatch Advisors's DGX Position: Q2 2026 in Review

Wasatch Advisors reduced its Quest Diagnostics (DGX) stake by 5.2% in Q2 2026, selling an estimated $182K and leaving 16,775 shares worth $3.56M. The position accounts for 0.02% of the portfolio, ranked #193.

Wasatch Advisors first reported a position in DGX in Q2 2016 and has held it in 13 quarters since. The position peaked at $8.77M in Q2 2016. 380 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Wasatch Advisors held 16,775 shares of Quest Diagnostics worth $3.56M as of Q2 2026.
  • Wasatch Advisors sold 927 Quest Diagnostics shares in Q2 2026, an estimated $182K.
  • Quest Diagnostics made up 0.02% of Wasatch Advisors's portfolio in Q2 2026, its #193 holding.
  • Wasatch Advisors first reported a position in Quest Diagnostics in Q2 2016 and has held it in 13 quarters since.
  • Wasatch Advisors's Quest Diagnostics position peaked at $8.77M in Q2 2016.
  • 380 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Wasatch Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.